Inventor · disambiguated record
Jennifer D. Venable
Also filed as: VENABLE JENNIFER · VENABLE JENNIFER D · VENABLE JENNIFER DIANE
51 granted patents·11 pending applications·207 citations·filing 2003–2024
98Inventor score
Files withJANSSEN PHARMACEUTICA NV39RESPIVERT LTD8EDWARDS JAMES P7HUTCHISON MEDIPHARMA LTD2JANSSEN BIOTECH INC2
Top patents by PatentIndex Score
62 records- 0197US9624196B2Inhibitor of p38 MAP kinaseRESPIVERT LTD·Filed 2016·Granted Apr 18, 2017·15 cites·5 claims
- 0296US9447076B2Inhibitor of p38 map kinaseRESPIVERT LTD·Filed 2015·Granted Sep 20, 2016·16 cites·18 claims
- 0396US7507737B2Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4receptorJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 24, 2009·37 cites·31 claims
- 0495US7253200B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Aug 7, 2007·24 cites·21 claims
- 0593US11827638B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·2 cites·3 claims
- 0693US7928131B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Apr 19, 2011·14 cites·40 claims
- 0791US12065446B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 20, 2024·1 cites·4 claims
- 0891US10981911B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 20, 2021·6 cites·2 claims
- 0991US10717745B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 21, 2020·5 cites·26 claims
- 1091US8598189B2Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Dec 3, 2013·12 cites·4 claims
- 1190US10934310B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 2, 2021·4 cites·7 claims
- 1290US8343989B2Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 1, 2013·10 cites·21 claims
- 1389US10947252B2Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 16, 2021·3 cites·1 claims
- 1486US2024383914A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1585US8431704B2Quinoline or isoquinoline substituted P2X7 antagonistsLOVE CHRISTOPHER JOHN·Filed 2009·Granted Apr 30, 2013·24 cites·12 claims
- 1685US8084466B2Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptorKINDRACHUK DAVID E·Filed 2008·Granted Dec 27, 2011·8 cites·20 claims
- 1784US11319329B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·7 claims
- 1884US8193178B2Thieno- and furo-pyrimidine modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2008·Granted Jun 5, 2012·6 cites·8 claims
- 1984US7705149B2Benzoimidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Apr 27, 2010·4 cites·22 claims
- 2083US10294216B2Pyrazolyl ureas as kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted May 21, 2019·1 cites·13 claims
- 2180US7432378B2Benzoimidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Oct 7, 2008·8 cites·25 claims
- 2279US8962644B2Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Feb 24, 2015·2 cites·4 claims
- 2377US7723359B2Benzoimidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted May 25, 2010·1 cites·24 claims
- 2477US7723526B2Benzoimidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted May 25, 2010·1 cites·23 claims
- 2577US7662966B2Benzoimidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Feb 16, 2010·1 cites·11 claims
- 2676US11634406B2Inhibitor of p38 MAP kinaseRESPIVERT LTD·Filed 2020·Granted Apr 25, 2023·0 cites·10 claims
- 2776US11142515B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2019·Granted Oct 12, 2021·0 cites·9 claims
- 2876US9884845B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Feb 6, 2018·1 cites·17 claims
- 2974US11427601B1Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 30, 2022·0 cites·44 claims
- 3073US12215111B2Imidazopyridazine IL-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Feb 4, 2025·0 cites·24 claims
- 3170US10815217B2Inhibitor of p38 MAP kinaseRESPIVERT LTD·Filed 2018·Granted Oct 27, 2020·0 cites·13 claims
- 3270US2025206744A1Imidazopyridazine il-17 inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 3368US10045980B2Inhibitor of p38 map kinaseRESPIVERT LTD·Filed 2017·Granted Aug 14, 2018·0 cites·13 claims
- 3467US11897900B2Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 13, 2024·0 cites·17 claims
- 3567US2009137608A1Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2009·Application pending·0 cites
- 3667US2009247508A1Benzoimidazole CompoundsEDWARDS JAMES P·Filed 2008·Application pending·0 cites
- 3766US8039498B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Oct 18, 2011·0 cites·20 claims
- 3865US10800792B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 13, 2020·0 cites·4 claims
- 3965US7956071B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jun 7, 2011·0 cites·34 claims
- 4065US7956066B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jun 7, 2011·0 cites·40 claims
- 4165US7956057B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jun 7, 2011·0 cites·34 claims
- 4265US7951808B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 31, 2011·0 cites·40 claims
- 4364US10822348B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·10 claims
- 4463US8716475B22-aminopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 6, 2014·0 cites·12 claims
- 4558US10689396B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 23, 2020·0 cites·23 claims
- 4658US8017600B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Sep 13, 2011·0 cites·32 claims
- 4758US8017639B2Imidazole compoundsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Sep 13, 2011·0 cites·34 claims
- 4858US2023013755A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 4957US9365548B2Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 14, 2016·0 cites·2 claims
- 5057US8937075B2Thieno- and furo-pyrimidine modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2012·Granted Jan 20, 2015·0 cites·9 claims
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jennifer D. Venable files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →